Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
POET, formerly known as Broin Companies, is a global leader in the biorefining industry and the world's largest producer of bioethanol. Headquartered in Sioux Falls, South Dakota, the company utilizes advanced industrial biotechnology to convert agricultural products into sustainable fuel, animal feed, and bio-based chemicals. Their proprietary BPX technology is a revolutionary cold-fermentation process that converts starch to ethanol without the use of heat, significantly reducing energy consumption and greenhouse gas emissions. POET operates a vast network of biorefineries across the United States, producing billions of gallons of renewable fuel annually. Beyond ethanol, the company produces high-quality animal nutrition products and corn oil for biodiesel production, positioning itself as a key player in the transition to a low-carbon economy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Broin Companies.